Skip to main content
. 2015 Dec 3;2015(12):CD002243. doi: 10.1002/14651858.CD002243.pub3
Methods Randomized controlled trial with parallel groups
1 centre
Participants Adults (n = 26) with ARDS and sepsis, including septic shock (n = 12)
Interventions
  • Hydrocortisone (100 mg intravenous bolus 8‐hourly for 7 consecutive days)

  • Placebo (normal saline)

Outcomes PRIMARY
  • Unclear


SECONDARY
  • 28‐Day mortality

  • Prevalence of shock within 28 days

  • SOFA score (information for SOFA score at day 7 not available)

  • ICU length of stay

  • Safety

Notes Study location: China
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomization scheme
Allocation concealment (selection bias) Unclear risk No explicit information in the manuscript
Blinding (performance bias and detection bias) All outcomes Unclear risk No explicit information in the manuscript
Incomplete outcome data (attrition bias) All outcomes Unclear risk No explicit information in the manuscript
Selective reporting (reporting bias) Unclear risk No information
Other bias Unclear risk No information